keyword
MENU ▼
Read by QxMD icon Read
search

Fibroscan

keyword
https://www.readbyqxmd.com/read/29790083/point-quantification-elastography-in-the-evaluation-of-liver-elasticity-in-healthy-volunteers-a-reliability-study-based-on-operator-expertise
#1
Cristina Felicani, Chiara De Molo, Horia Stefanescu, Fabio Conti, Elena Mazzotta, Veronica Gabusi, Elena Nardi, Antonio Maria Morselli-Labate, Pietro Andreone, Carla Serra
PURPOSE: The assessment of liver fibrosis is essential in the management of patients with chronic liver diseases. Liver biopsy is considered the gold standard procedure for this purpose, though the recent development of new elastosonographic techniques to measure liver stiffness (LS) noninvasively is promising. Point quantification elastography (PQE) showed good results but less is known about the level of skill needed to obtain reliable results. The aim of the study was to evaluate the reproducibility of PQE in assessing LS in healthy subjects comparing three operators with different expertise...
May 22, 2018: Journal of Ultrasound
https://www.readbyqxmd.com/read/29779697/usefulness-of-controlled-attenuation-parameter-for-detecting-increased-arterial-stiffness-in-general-population
#2
Hyo Eun Park, Heesun Lee, Su-Yeon Choi, Min-Sun Kwak, Jong In Yang, Jeong Yoon Yim, Goh Eun Chung
BACKGROUND: Liver fibroscan has recently been suggested as an alternative method to measure liver steatosis noninvasively. In this study, we evaluated usefulness of controlled attenuation parameter (CAP) for detecting increased arterial stiffness in general population. METHODS: A total of 515 asymptomatic patients without potential cause of liver disease who had liver fibroscan and cardio-ankle vascular index (CAVI) during their health check-up exams were included...
May 4, 2018: Digestive and Liver Disease
https://www.readbyqxmd.com/read/29774454/analysis-of-three-ultrasound-elastography-techniques-for-grading-liver-fibrosis-in-patients-with-chronic-hepatitis-b
#3
Xinping Ren, Shujun Xia, Zhongxin Ni, Weiwei Zhan, Jianqiao Zhou
BACKGROUND: Evaluation of liver fibrosis is important to assess prognosis and guide the treatment for chronic hepatitis B. OBJECTIVE: To analyze and compare transient, point, and two-dimensional (2D) shear wave elastography techniques in grading the liver fibrosis. METHODS: Based on the severity of liver inflammation and fibrosis (Scheuer criteria), 158 patients with chronic hepatitis B were assigned into group 1 (either G or S classification < 2) or group 2 (either G or S classification ≥ 2)...
May 17, 2018: La Radiologia Medica
https://www.readbyqxmd.com/read/29768686/prevalence-and-predictive-factors-of-moderate-severe-liver-steatosis-in-chronic-hepatitis-c-chc-infected-patients-evaluated-with-controlled-attenuation-parameter-cap
#4
Ana Carolina Cardoso, Renata M Perez, Claudio de Figueiredo-Mendes, Nathalie Carvalho Leite, Henrique Sergio Moraes Coelho, Cristiane A Villela-Nogueira
A novel controlled attenuation parameter (CAP) using FibroScan® has been developed for assessment of liver steatosis. The aim was to evaluate the frequency and associated factors for moderate/severe steatosis evaluated by CAP in CHC patients submitted to transient elastography (TE) by FibroScan® . CHC patients underwent TE with CAP evaluation. The classification of steatosis was defined as: CAP < 222 dB/m = S0; CAP ≥ 222 dB/m and <233dB /m = S1; ≥233 dB/m <290dB/m = S2 and >= 290 dB/m = S3...
May 16, 2018: Journal of Viral Hepatitis
https://www.readbyqxmd.com/read/29768330/risk-factors-for-osteoporosis-in-liver-cirrhosis-patients-measured-by-transient-elastography
#5
Jian-Ping Zheng, Hai-Xiong Miao, Shao-Wei Zheng, Wei-le Liu, Chu-Qun Chen, Hao-Bo Zhong, Sheng-Fa Li, Yong-Ping Fang, Chun-Han Sun
Osteoporosis or osteopenia is a common complication in patients with cirrhosis, but little is known about the risk factors for the occurrence of osteoporosis.Patients with liver cirrhosis due to chronic virus infection and alcoholic abuse were enrolled. Bone mineral density (BMD) was determined using dual-energy x-ray absorptiometry (DXA). Osteoporosis was diagnosed according to WHO criteria. The severity of liver stiffness was measured by Fibroscan. Demographic data, such as age, gender, weight, height, and body mass index (BMI), were collected...
May 2018: Medicine (Baltimore)
https://www.readbyqxmd.com/read/29749328/effect-of-ursodeoxycholic-acid-and-vitamin-e-in-the-prevention-of-liver-injury-from-methotrexate-in-pediatric-leukemia
#6
Mohammadreza Bordbar, Nader Shakibazad, Mohammadreza Fattahi, Sezaneh Haghpanah, Naser Honar
BACKGROUND/AIMS: Ursodeoxycholic acid (UDCA) and antioxidants such as vitamin E are considered to have a protective role in preventing chemotherapy-induced liver damage. The aim of this study was to assess the efficacy of these agents for hepatoprotection in pediatric patients with B-cell acute lymphoblastic leukemia (ALL), who were treated with methotrexate in their maintenance phase of treatment. MATERIALS AND METHODS: Eighty children with B-cell ALL were randomly divided into four groups...
March 2018: Turkish Journal of Gastroenterology: the Official Journal of Turkish Society of Gastroenterology
https://www.readbyqxmd.com/read/29739341/hbv-and-hiv-viral-load-but-not-microbial-translocation-or-immune-activation-are-associated-with-liver-fibrosis-among-patients-in-south-africa
#7
Tongai Gibson Maponga, Monique I Andersson, Christoffel J van Rensburg, Joop E Arends, Jantjie Taljaard, Wolfgang Preiser, Richard H Glashoff
BACKGROUND: Co-infection with HIV negatively impacts the progression of chronic hepatitis B virus (HBV) infection, including causing rapid progression to liver fibrosis. Sub-Saharan Africa represents arguably the most important intersection of high endemicity of both chronic hepatitis B virus (HBV) infection and HIV infection. METHODS: We recruited 46 HBV/HIV-co-infected; 47 HBV-monoinfected; 39 HIV-monoinfected; and 37 HBV/HIV-uninfected patients from Tygerberg Hospital, Cape Town, South Africa...
May 8, 2018: BMC Infectious Diseases
https://www.readbyqxmd.com/read/29731186/a-novel-fibroscan-examination-dedicated-to-spleen-stiffness-measurement
#8
Cécile Bastard, Véronique Miette, Paul Calès, Horia Stefanescu, Davide Festi, Laurent Sandrin
Esophageal varices (EVs) are among the most severe complications of cirrhosis, with a prevalence of 50% to 60% among cirrhotic patients. International guidelines therefore recommend that cirrhotic patients should be screened for the presence of EVs. The main objective of this study was to introduce a new spleen-dedicated FibroScan (Echosens, Paris, France) examination and to assess its performance in detecting large EVs (grade 2 and 3). This novel examination has been validated in simulation and phantom studies and has been used in a population of patients with chronic liver disease...
May 3, 2018: Ultrasound in Medicine & Biology
https://www.readbyqxmd.com/read/29729368/a-combined-model-based-on-spleen-stiffness-measurement-and-baveno-vi-criteria-to-rule-out-high-risk-varices-in-advanced-chronic-liver-disease
#9
Antonio Colecchia, Federico Ravaioli, Giovanni Marasco, Agostino Colli, Elton Dajti, Annarita Di Biase, Maria Letizia Bacchi Reggiani, Annalisa Berzigotti, Massimo Pinzani, Davide Festi
BACKGROUND & AIMS: Recently, Baveno VI guidelines suggested that esophagogastroduodenoscopy (EGD) can be avoided in patients with cACLD who have a liver stiffness measurement (LSM) < 20 kPa and platelet count >150,000/mm3 . We aimed to: assess the performance of spleen stiffness measurement (SSM) in ruling out patients with high-risk varices (HRV); validate Baveno VI criteria in a large population and assess how the sequential use of Baveno VI criteria and SSM could safely avoid the need for endoscopy...
May 2, 2018: Journal of Hepatology
https://www.readbyqxmd.com/read/29709450/the-combination-of-5-serum-markers-compared-to-fibroscan-to-predict-significant-liver-fibrosis-in-patients-with-chronic-hepatitis-b-virus
#10
Huimin Dong, Changzhi Xu, Wenying Zhou, Yuan Liao, Junyan Cao, Zhaoxia Li, Bo Hu
BACKGROUND: We evaluated the performance of serum hyaluronan (HA), procollagen type III N-terminal peptide (PIIINP), type IV collagen (IVC), laminin (LN), alanine aminotransferase (ALT), and aspartate aminotransferase (AST), compared to transient elastography (FibroScan) in predicting significant liver fibrosis. METHODS: We therefore determined 4 serum fibrosis markers, FibroScan and liver biopsy in 70 consecutive adult patients with chronic hepatitis B. According to a modified Scheuer scoring system, significant fibrosis was defined as fibrosis stage ≥S2...
April 28, 2018: Clinica Chimica Acta; International Journal of Clinical Chemistry
https://www.readbyqxmd.com/read/29709217/glycogenic-hepatopathy
#11
Johad Khoury, Yaniv Zohar, Naim Shehadeh, Tarek Saadi
BACKGROUND: Glycogenic hepatopathy (GH) is a disorder associated with uncontrolled diabetes mellitus, most commonly type 1, expressed as right upper quadrant abdominal pain, hepatomegaly and increased liver enzymes. The diagnosis may be difficult, because laboratory and imaging tests are not pathognomonic. Although GH may be suggested based on clinical presentation and imaging studies, the gold standard for diagnosis is a liver biopsy, showing a significant accumulation of glycogen within the hepatocytes...
April 2018: Hepatobiliary & Pancreatic Diseases International: HBPD INT
https://www.readbyqxmd.com/read/29705030/adherence-to-quality-criteria-improves-concordance-between-transient-elastography-and-elastpq-for-liver-stiffness-assessment-a-multicenter-retrospective-study
#12
Giovanna Ferraioli, Annalisa De Silvestri, Thomas Reiberger, Simon D Taylor-Robinson, Robert J de Knegt, Laura Maiocchi, Ruxandra Mare, Theresa Bucsics, Sebastiana Atzori, Carmine Tinelli, Ioan Sporea
BACKGROUND: Assessment of liver stiffness provides important diagnostic and prognostic information in patients with chronic liver disease. AIMS: To investigate whether the use of quality criteria (i) improves the concordance between transient elastography (TE) and a novel point shear wave elastography technique (ElastPQ® ) and (ii) impacts on the performance of ElastPQ® for liver fibrosis staging using TE as the reference standard. METHODS: In this multicenter retrospective study, data of patients undergoing liver stiffness measurements (LSM) in five European centers were collected...
April 4, 2018: Digestive and Liver Disease
https://www.readbyqxmd.com/read/29702515/integrated-care-for-the-use-of-direct-acting-antivirals-in-patients-with-chronic-hepatitis-c-and-substance-use-disorder
#13
Jean-Baptiste Trabut, Camille Barrault, Hélène Charlot, Damien Carmona, Anne Bourdel, Mustapha Benslimane, Murielle François, Willy Kini-Matondo, Richard Causse, Françoise Roudot-Thoraval, Christophe Hézode
OBJECTIVES: Since little is currently known about predictors of response to direct-acting antiviral agents (DAAs) in people who inject drugs, we undertook an analysis of patients attending a hepatitis clinic with addiction services (outpatient clinics and inpatient services) to examine the outcomes associated with the treatment of difficult-to-manage patients with substance use. Our experience was based on integrated care. METHOD: A retrospective analysis was undertaken of 50 patients with hepatitis C virus (HCV) and a history of addiction who received treatment with DAAs, according to European guidelines...
April 26, 2018: Journal of Addiction Medicine
https://www.readbyqxmd.com/read/29696462/longitudinal-monitoring-of-liver-fibrosis-status-by-transient-elastography-in-chronic-hepatitis-b-patients-during-long-term-entecavir-treatment
#14
Sheng-Di Wu, Li-Li Liu, Ji-Lin Cheng, Yun Liu, Li-Sha Cheng, Si-Qi Wang, Wei Ma, Li-Ping Chen, Yu-Jen Tseng, Ji-Yao Wang, Xi-Zhong Shen, Wei Jiang
The correlation between improvement in longitudinal liver stiffness and fibrosis regression has not been properly evaluated during long-term antiviral therapy in chronic hepatitis B (CHB) patients. In this study, liver stiffness was serially performed by FibroScan® every 26 weeks in a prospective cohort of CHB patients receiving entecavir. Results were compared with liver biopsies at baseline and week 78. A total of 120 treatment-naïve CHB patients were analyzed, in which 54 (45%) patients had fibrosis regression at 78 weeks of antiviral therapy...
April 25, 2018: Clinical and Experimental Medicine
https://www.readbyqxmd.com/read/29692949/laboratory-tests-liver-vessels-color-doppler-sonography-and-fibroscan-findings-in-patients-with-nonalcoholic-fatty-liver-disease-an-observation-study
#15
Ahmad Alizadeh, Fariborz Mansour-Ghanaei, Ava Roozdar, Farahnaz Joukar, Masood Sepehrimanesh, Seyedeh Amineh Hojati, Alireza Mansour-Ghanaei
Objective: Determination of the amount of parenchymal damage in nonalcoholic fatty liver disease (NAFLD) is crucial to choose the best treatment and management. Aim: Here, the associations between laboratory data and severity of steatosis and fibrosis plus hepatic vessel Doppler indices in NAFLD patients were investigated. Patients and Methods: Fifty patients (20 males and 30 females) with NAFLD criteria were enrolled. Fatty liver was graded by sonography (SGFL) and FibroScan (FGFL)...
2018: Journal of Clinical Imaging Science
https://www.readbyqxmd.com/read/29661260/implementing-routine-blood-borne-virus-testing-for-hcv-hbv-and-hiv-at-a-london-emergency-department-uncovering-the-iceberg
#16
S Parry, N Bundle, S Ullah, G R Foster, K Ahmad, C Y W Tong, S Balasegaram, C Orkin
UK guidelines recommend routine HIV testing in high prevalence emergency departments (ED) and targeted testing for HBV and HCV. The 'Going Viral' campaign implemented opt-out blood-borne virus (BBV) testing in adults in a high prevalence ED, to assess seroprevalence, uptake, linkage to care (LTC) rates and staff time taken to achieve LTC. Diagnosis status (new/known/unknown), current engagement in care, and severity of disease was established. LTC was defined as patient informed plus ⩾1 clinic visit. A total of 6211/24 981 ED attendees were tested (uptake 25%); 257 (4...
April 17, 2018: Epidemiology and Infection
https://www.readbyqxmd.com/read/29625923/wilson-s-disease-a-2017-update
#17
Aurélia Poujois, France Woimant
Wilson's disease (WD) is characterised by a deleterious accumulation of copper in the liver and brain. It is one of those rare genetic disorders that benefits from effective and lifelong treatments that have dramatically transformed the prognosis of the disease. In Europe, its clinical prevalence is estimated at between 1.2 and 2/100,000 but the genetic prevalence is higher, at around 1/7000. Incomplete penetrance of the gene or the presence of modifier genes may account for the difference between the calculated genetic prevalence and the number of patients diagnosed with WD...
April 3, 2018: Clinics and Research in Hepatology and Gastroenterology
https://www.readbyqxmd.com/read/29625910/corrigendum-to-differences-in-liver-stiffness-values-obtained-with-new-ultrasound-elastography-machines-and-fibroscan-a-comparative-study-dig-liver-dis-49-2017-802-808
#18
Fabio Piscaglia, Veronica Salvatore, Lorenzo Mulazzani, Vito Cantisani, Antonio Colecchia, Roberto Di Donato, Cristina Felicani, Alessia Ferrarini, Nesrine Gamal, Valentina Grassoc, Giovanni Marasco, Elena Mazzotta, Federico Ravaioli, Giacomo Ruggieri, Ilaria Serio, Joules Fabrice Sitouok Nkamgho, Carla Serra, Davide Festi, Cosima Schiavone, Luigi Bolondi
No abstract text is available yet for this article.
April 3, 2018: Digestive and Liver Disease
https://www.readbyqxmd.com/read/29611385/diagnosis-of-liver-fibrosis-with-wisteria-floribunda-agglutinin-positive-mac-2-binding-protein-wfa-m2bp-among-chronic-hepatitis-b-patients
#19
Dong Wook Jekarl, Hyunyu Choi, Seungok Lee, Jung Hyun Kwon, Sung Won Lee, Hein Yu, Myungshin Kim, Yonggoo Kim, Pil Soo Sung, Seung Kew Yoon
BACKGROUND: Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA-M2BP) is a protein with altered glycosylation that reacts with lectin, and was recently identified as a useful non-invasive biomarker for the diagnosis of liver fibrosis in patients with hepatitis C virus infection.This study aimed to evaluate the diagnostic efficacy of WFA-M2BP for liver fibrosis in the context of hepatitis B virus (HBV). METHODS: We enrolled 151 patients infected with HBV...
July 2018: Annals of Laboratory Medicine
https://www.readbyqxmd.com/read/29603365/can-the-same-controlled-attenuation-parameter-cut-offs-be-used-for-m-and-xl-probes-for-diagnosing-hepatic-steatosis
#20
Wah-Kheong Chan, Nik Raihan Nik Mustapha, Sanjiv Mahadeva, Vincent Wai-Sun Wong, Jenny Yeuk-Ki Cheng, Grace Lai-Hung Wong
BACKGROUND AND AIM: There are limited studies on controlled attenuation parameter (CAP) using Fibroscan XL probe for the diagnosis of hepatic steatosis grade. The aim of this study was to determine whether previously defined optimal cut-offs for CAP using the M probe could be applied for the XL probe. METHODS: Adult patients with chronic liver disease who had a liver biopsy and examination with both the M and XL probes were included. Previously defined optimal cut-offs for CAP using the M probe were used for the diagnosis of steatosis grades ≥S1, ≥S2, and S3 (248, 268, and 280 dB/m, respectively)...
March 30, 2018: Journal of Gastroenterology and Hepatology
keyword
keyword
14687
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"